- Healthcare
- M&A
, ,
Novo Nordisk (NVO) announced Saturday that its pending acquisition of 3 Catalent (NYSE:CTLT) accumulation sites is expected to adjacent wrong days arsenic its genitor entity satisfied each regulatory conditions to bargain nan U.S. statement manufacturer.
The announcement followed nan U.S. Federal
Recommended For You
More Trending News
See More »